Stewart Cooper

3.3k total citations · 1 hit paper
34 papers, 2.2k citations indexed

About

Stewart Cooper is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, Stewart Cooper has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 24 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Stewart Cooper's work include Hepatitis C virus research (24 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (16 papers). Stewart Cooper is often cited by papers focused on Hepatitis C virus research (24 papers), Hepatitis B Virus Studies (22 papers) and Liver Disease Diagnosis and Treatment (16 papers). Stewart Cooper collaborates with scholars based in United States, Canada and Poland. Stewart Cooper's co-authors include Peter Parham, Erin J. Adams, Ann L. Erickson, David Y. Chien, Christopher M. Walker, Michael Houghton, Amy J. Weiner, Joe Kansopon, Teresa L. Wright and Lia Avanesyan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Immunity.

In The Last Decade

Stewart Cooper

32 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of a Successful Immune Response against Hepatitis C Virus

1999 658 citations Stewart Cooper, Ann L. Erickson et al. Immunity profile →

Peers

Countries citing papers authored by Stewart Cooper

Since Specialization

Citations

This map shows the geographic impact of Stewart Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stewart Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stewart Cooper more than expected).

Fields of papers citing papers by Stewart Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stewart Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stewart Cooper. The network helps show where Stewart Cooper may publish in the future.

Co-authorship network of co-authors of Stewart Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Stewart Cooper. A scholar is included among the top collaborators of Stewart Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stewart Cooper. Stewart Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modelling T-cell immunity against hepatitis C virus with liver organoids in a microfluidic coculture system 2022 ·Open Biology ·Vaishaali Natarajan, Camille R. Simoneau, Ann L. Erickson, (unknown), Jody L. Baron, Stewart Cooper, Todd C. McDevitt, Mélanie Ott	41
2	Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B 2022 ·The American Journal of Gastroenterology ·Norah A. Terrault, Anna S. Lok, Abdus S. Wahed, Marc G. Ghany, Robert P. Perrillo, Michael Fried, David Wong, Mandana Khalili, Daryl Lau, Richard K. Sterling, Adrian M. Di Bisceglie, Mauricio Lisker‐Melman, Stewart Cooper, Ray Chung, Keyur Patel, Lewis R. Roberts, Steven H. Belle, Harry L.A. Janssen	11
3	Clinical significance of quantitative e antigen in a cohort of hepatitis B virus‐infected children and adults in North America 2021 ·Journal of Viral Hepatitis ·Stewart Cooper, Wendy C. King, Douglas Mogul, Marc G. Ghany, Kathleen B. Schwarz	4
4	Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study 2021 ·Journal of Viral Hepatitis ·William M. Lee, Wendy C. King, Harry L.A. Janssen, Marc G. Ghany, Robert J. Fontana, Michael Fried, Richard K. Sterling, Jordan J. Feld, (unknown), Douglas Mogul, Stewart Cooper, Adrian M. Di Bisceglie	9
5	Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers 2019 ·Epigenetics & Chromatin ·Charles E. Mordaunt, Dorothy A. Kieffer, Noreene M. Shibata, Anna Członkowska, Tomasz Litwin, Karl-Heinz Weiss, Yihui Zhu, Christopher L. Bowlus, Souvik Sarkar, Stewart Cooper, Yu‐Jui Yvonne Wan, Mohamed R. Ali, Janine M. LaSalle, Valentina Medici	28
6	Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B 2019 ·Journal of Viral Hepatitis ·Adrian M. Di Bisceglie, Wendy C. King, Mauricio Lisker‐Melman, Mandana Khalili, Steven H. Belle, Jordan J. Feld, Marc G. Ghany, Harry L.A. Janssen, Daryl Lau, William M. Lee, Simon C. Ling, Stewart Cooper, Philip Rosenthal, Kathleen B. Schwarz, Richard K. Sterling, Jeffrey Teckman, Norah A. Terrault	16
7	An OX40/OX40L interaction directs successful immunity to hepatitis B virus 2018 ·Science Translational Medicine ·Jean Publicover, Anuj Gaggar, (unknown), Ugur Halac, (unknown), Amanda Goodsell, Lia Avanesyan, Stephen L. Nishimura, Meghan Holdorf, Keith G. Mansfield, (unknown), (unknown), Michael Croft, Adil E. Wakil, Philip Rosenthal, (unknown), Stewart Cooper, Jody L. Baron	34
8	Entecavir and Peginterferon Alfa‐2a in Adults With Hepatitis B e Antigen–Positive Immune‐Tolerant Chronic Hepatitis B Virus Infection 2018 ·Hepatology ·Jordan J. Feld, Norah A. Terrault, (unknown), Steven H. Belle, Raymond T. Chung, Naoky Tsai, Mandana Khalili, Robert Perrillo, Stewart Cooper, Marc G. Ghany, Harry L.A. Janssen, Anna S. Lok	32
9	Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial 2015 ·The Lancet Infectious Diseases ·Christopher Koh, Laëtitia Canini, Harel Dahari, Xiongce Zhao, Susan L. Uprichard, Vanessa Haynes–Williams, Mark A. Winters, Gitanjali Subramanya, Stewart Cooper, Peter A. Pinto, E.F. Wolff, Rachel Bishop, Ma Ai Thanda Han, Scott J. Cotler, David E. Kleiner, Onur Keskın, Ramazan Idılman, Cihan Yurdaydın, Jeffrey S. Glenn, Theo Heller	187
10	Immune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients 2014 ·Proceedings of the National Academy of Sciences ·Courtney A. Crane, Kathryn Austgen, Kristen Haberthur, (unknown), Kara White Moyes, Lia Avanesyan, Lawrence Fong, Michael J. Campbell, Stewart Cooper, Scott A. Oakes, Andrew T. Parsa, Lewis L. Lanier	144
11	Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B 2013 ·Journal of Clinical Investigation ·Jean Publicover, Anuj Gaggar, Stephen L. Nishimura, Christine M. Van Horn, Amanda Goodsell, Marcus O. Muench, R. Lee Reinhardt, Nico van Rooijen, Adil E. Wakil, (unknown), Jason G. Cyster, David J. Erle, Philip Rosenthal, Stewart Cooper, Jody L. Baron	72
12	IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B 2011 ·Journal of Clinical Investigation ·Jean Publicover, Amanda Goodsell, Stephen L. Nishimura, Sílvia Vilarinho, Zhi‐En Wang, Lia Avanesyan, Rosanne Spolski, Warren J. Leonard, Stewart Cooper, Jody L. Baron	107
13	Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic 2010 ·Journal of Viral Hepatitis ·Robert G. Gish, Stewart Cooper	21
14	A case‐control study of factors associated with resolution of hepatitis C viremia in former blood donors (CME) 2010 ·Transfusion ·Leslie H. Tobler, (unknown), Zhanna Kaidarova, (unknown), (unknown), (unknown), Anne M. Guiltinan, Stewart Cooper, Michael P. Busch, Edward L. Murphy	10
15	Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection 2009 ·The Journal of Infectious Diseases ·Kimberly Page, Judith A. Hahn, Jennifer L. Evans, Stephen Shiboski, Paula J. Lum, Eric Delwart, Leslie H. Tobler, William Andrews, Lia Avanesyan, Stewart Cooper, Michael P. Busch	237
16	High levels of subgenomic HCV plasma RNA in immunosilent infections 2007 ·Virology ·Flavien Bernardin, Susan L. Stramer, Barbara Rehermann, Kimberly Page, Stewart Cooper, David R. Bangsberg, Judith A. Hahn, Leslie H. Tobler, Michael P. Busch, Eric Delwart	20
17	Antibodies to a novel antigen in acute hepatitis C virus infections 2006 ·Vox Sanguinis ·Leslie H. Tobler, Susan L. Stramer, David Y. Chien, (unknown), (unknown), Bruce H. Phelps, Stewart Cooper, Michael P. Busch	5
18	Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans 2000 ·Immunity ·Salim I. Khakoo, Raja Rajalingam, Benny P. Shum, (unknown), (unknown), David Muir, Flávio Canavez, Stewart Cooper, Nicholas M. Valiante, Lewis L. Lanier, Peter Parham	237
19	Analysis of a Successful Immune Response against Hepatitis C Virus breakdown → 1999 ·Immunity ·Stewart Cooper, Ann L. Erickson, Erin J. Adams, Joe Kansopon, Amy J. Weiner, David Y. Chien, Michael Houghton, Peter Parham, Christopher M. Walker	658
20	TCR peptide vaccination induced TH2 immune regulation in multiple sclerosis 1996 ·The FASEB Journal ·Arthur A. Vandenbark, Y. K. Chou, Ruth H. Whitham, Abigail C. Buenafe, (unknown), D. Cavanagh, Stewart Cooper, George A. Hashim, Halina Offner, Dennis Bourdette	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact